% 0期刊文章%一个引信郑% Liangliang邱%长陈%一个林Xiaodan嬴政% %俊杰他%鑫林%齐放他%一个玲玲昙花林% %一个丽丽王%风林% Kang杨%一个林易铸造林% %一个傅应%宁王%志强王% T协会4 qa-specific远D4Z4 Hypomethylation与疾病严重程度和发展Facioscapulohumeral肌肉萎缩症% D R 10.1212 / WNL 2023%。0000000000207418 % J首页神经病学% P 10.1212 / WNL。0000000000207418 % X目的:检查是否区域甲基化水平在最末端D4Z4重复单位(俄文)4 qa-permissive单体型与疾病严重程度和进展有关facioscapulohumeral肌肉萎缩症1型(FSHD1)。方法:这是一个21年,回顾和观察性队列研究在中国福建Neuromedical中心(FNMC)。甲基化水平的最末端D4Z4俄文,包括10个论文认定,被重亚硫酸盐测序评估在所有参与者。FSHD1患者基于甲基化比例四分位数分层分为4组,包括LM1(低甲基化),LM2中间甲基化(低),LM3(中间高甲基化)和甲基化水平最高(HM)。患者运动功能的评价集中在下肢(LE)进展在基线和跟进。FSHD临床评分(CS)、age-corrected临床严重程度量表(ACSS)和改良Rankin规模被用来评估运动机能。结果:10论文认定的甲基化水平显著降低在所有823个基因证实FSHD1病人比341年健康对照组(高碳钢)。CpG6甲基化水平可以区分:1)从高碳钢FSHD1病人;2)从无症状/影响患者症状;3)LE患者参与从那些没有参与,与auc (95% CI)为0.9684(0.9584 - -0.9785),0.7417(0.6903 - -0.7931),和0.6386 (0.5816 - -0.6956)。 CpG6 methylation levels were negatively correlated with both CS (r = -0.392) and ACSS (r = -0.432), and positively correlated with onset age of first-ever muscle weakness (r = 0.297). For the LM1, LM2, LM3, and HM groups, the respective proportions of LE involvement were 52.9%, 44.2%, 36.9%, and 23.4%; and onset ages of LE involvement were 20, 26.5, 25, and 26.5 years. Cox regression analysis—adjusted for sex, age at examination, D4Z4 RU, and 4qA/B haplotype—showed that the LM1, LM2, and LM3 groups (i.e., groups with lower methylation levels) had a higher risk for independent ambulation loss, with HRs (95% CI) of 3.523 (1.565–7.930), 3.356 (1.458–7.727), and 2.956 (1.245–7.020), respectively.Conclusion: 4q35 distal D4Z4 hypomethylation is correlated with disease severity and progression to lower extremity involvement. %U //www.ez-admanager.com/content/neurology/early/2023/05/24/WNL.0000000000207418.full.pdf